Latest filing published 16 Jun 2023 for Prometheus Biosciences, Inc..
No signal scores available.
All filings by James Laur on record concern Prometheus Biosciences, Inc. Over a trading history stretching from 19 May 2023 to 16 June 2023, the count stands at 2 filings.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
Most recently, on 16 June 2023, the filings show a transaction in Prometheus Biosciences, Inc. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations